Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders

Cellular and Molecular Life Sciences : CMLS
Laura FantuzziLucia Lopalco

Abstract

The chemokine system mediates acute inflammation by driving leukocyte migration to damaged or infected tissues. However, elevated expression of chemokines and their receptors can contribute to chronic inflammation and malignancy. Thus, great effort has been taken to target these molecules. The first hint of the druggability of the chemokine system was derived from the role of chemokine receptors in HIV infection. CCR5 and CXCR4 function as essential co-receptors for HIV entry, with the former accounting for most new HIV infections worldwide. Not by chance, an anti-CCR5 compound, maraviroc, was the first FDA-approved chemokine receptor-targeting drug. CCR5, by directing leukocytes to sites of inflammation and regulating their activation, also represents an important player in the inflammatory response. This function is shared with CCR2 and its selective ligand CCL2, which constitute the primary chemokine axis driving the recruitment of monocytes/macrophages to inflammatory sites. Both receptors are indeed involved in the pathogenesis of several immune-mediated diseases, and dual CCR5/CCR2 targeting is emerging as a more efficacious strategy than targeting either receptor alone in the treatment of complex human disorders. In this...Continue Reading

References

Aug 1, 1997·The Journal of Clinical Investigation·J M FradeC Martínez-A
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·K ConantE O Major
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·M BabaM Fujino
Aug 31, 1999·Nature·M MelladoC Martínez-A
Mar 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·L LopalcoA G Siccardi
Jan 11, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T L SørensenR M Ransohoff
Feb 28, 2002·Journal of the Neurological Sciences·Elio ScarpiniGuglielmo Scarlato
Oct 11, 2002·Proceedings of the National Academy of Sciences of the United States of America·Enrique GonzalezSunil K Ahuja
Sep 23, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Janelle R SalkowitzMichael M Lederman
Jul 20, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T L SørensenF Sellebjerg
Feb 14, 2007·Acta Neurologica Scandinavica·Adam Szczuciński, Jacek Losy
Oct 17, 2007·Annual Review of Pharmacology and Toxicology·Shawn E Kuhmann, Oliver Hartley
May 13, 2008·Nature Reviews. Immunology·Florian Hladik, M Juliana McElrath
Jul 10, 2008·Multiple Sclerosis : Clinical and Laboratory Research·C TrebstM Stangel
Sep 12, 2008·The Journal of Biological Chemistry·Grant R Campbell, Stephen A Spector
Nov 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Hubert GaertnerOliver Hartley
Dec 17, 2008·Nature Reviews. Drug Discovery·Richard Horuk
Feb 14, 2009·The New England Journal of Medicine·Gero HütterEckhard Thiel
Apr 3, 2009·Current Opinion in HIV and AIDS·William C Olson, Jeffrey M Jacobson
May 15, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ekihiro SekiDavid A Brenner
Jun 30, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F SellebjergP Soelberg Sørensen

❮ Previous
Next ❯

Citations

Jan 7, 2020·Expert Opinion on Drug Metabolism & Toxicology·Miao MiaoGuangdi Li
Dec 19, 2019·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Benjamin J KopeckyKory J Lavine
Jan 30, 2020·Vaccines·Gabriel SiracusanoLucia Lopalco
May 29, 2020·BioMed Research International·Kauê F C Souza-SouzaPatrícia Burth
Aug 10, 2020·Experimental & Molecular Medicine·Seo-Young KooChang-Woo Lee
Aug 25, 2020·Journal of Clinical and Translational Hepatology·Yue Chang, Hai Li
Oct 8, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Min LiXiaoping Wang
Nov 18, 2020·Journal of Cellular Physiology·Yibing ChenZhengzhi Zou
Dec 5, 2020·Brain, Behavior, and Immunity·Deanna NeculaMiou Zhou
Jun 2, 2020·Virus Research·Joel Henrique EllwangerJosé Artur Bogo Chies
Aug 29, 2021·Journal for Immunotherapy of Cancer·David G DeNardoJohanna Bendell
Sep 1, 2021·Seminars in Immunopathology·Franziska MuscateNicola Gagliani
Sep 22, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Zilong YaoBin Yu
Jul 9, 2021·International Immunopharmacology·Sanjiv SinghV Ravichandiran

❮ Previous
Next ❯

Methods Mentioned

BETA
lavage

Clinical Trials Mentioned

NCT02217475
NCT03028740
NCT03517540

Software Mentioned

CENTAUR

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

Related Papers

American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics
Silvana Rodrigues de Albuquerque TaddeiTarcília Aparecida da Silva
© 2021 Meta ULC. All rights reserved